LAG3: The Next Frontier in Tumor Immunotherapy1. What is LAG3?
Lymphocyte-activation gene 3 (LAG3, CD223) is an important immune checkpoint molecule that was first cloned in 1990. Its gene shares approximately 20% homology with the CD4 gene, encod... Detailed information
LYPD3: An Emerging Star in Solid Tumor Therapy1. Overview of LYPD3
LYPD3 (Ly6/PLAUR Domain-Containing Protein 3), also known as C4.4A, is a glycosylphosphatidylinositol (GPI)-anchored cell membrane protein that plays a key role in tumor progression,... Detailed information